Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-07

Clinical Trial Update: A Study to Investigate the Effect of Food on Camlipixant Concentrations in Healthy Participants [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetics study assessing the effect of food on camlipixant concentrations in healthy participants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Camlipixant (camlipixant)

Snippet

Sponsor: Bellus Health Inc. - a GSK company | Conditions: Cough | Phase 1 | Status: COMPLETED